The Big Tobacco cancer cover-up is one of the most extensively documented corporate frauds in history. This is what their own internal files showed.
The Lawyer’s Memo
On 17 July 1963, Addison Yeaman sat down at his desk in Louisville, Kentucky, and wrote a memo. Yeaman was General Counsel at Brown & Williamson Tobacco Corporation, one of America’s largest cigarette manufacturers. He had been reviewing research commissioned from Battelle Memorial Institute — scientific work the company had paid for and kept strictly internal. The memo was marked for limited circulation. It was never intended to leave the building.
Yeaman was not a sentimentalist. He wrote in the careful, precise language of a corporate lawyer. But partway through the document, the careful language gave way to something unusually direct. He had been considering the company’s position on nicotine. He had read the science. He wrote what he found.
Eleven words. “We are, then, in the business of selling nicotine, an addictive drug.”
The memo sat in Brown & Williamson’s files for thirty-one years. When it finally came to light, the company’s chief executive had just testified under oath to the United States Congress that nicotine was not addictive. He had said he believed it. The word had been chosen carefully. So had Yeaman’s, three decades earlier. The difference was that Yeaman had written his in private, when there was no reason to lie.
A Frank Statement
By 1953, the scientific case against cigarettes had begun to reach the public. That year, Reader’s Digest published a summary of emerging research under the title “Cancer by the Carton.” The evidence was not yet definitive, but it was accumulating — population studies, animal studies, cellular analysis, chemical analysis. Researchers were linking lung cancer to smoking with increasing confidence.
The tobacco industry needed a response. In December 1953, the presidents of six major American tobacco companies — American Tobacco, R.J. Reynolds, Philip Morris, Benson & Hedges, US Tobacco, and Brown & Williamson — gathered at the Plaza Hotel in New York. They did not commission independent research into their products’ safety. They hired a public relations firm. Hill & Knowlton was given the task of managing the problem.
On 4 January 1954, the industry published what it called “A Frank Statement to Cigarette Smokers.” It ran in over 400 newspapers across the United States, reaching an estimated 43 million people. The statement acknowledged public concern, promised to support research, and assured the public that the manufacturers placed their customers’ health above all other considerations. It said the existing evidence was disputed and inconclusive.
The Tobacco Industry Research Committee was announced alongside it — presented as an independent scientific body that would pursue the truth wherever it led. Internal documents later confirmed what it actually was. Addison Yeaman, writing nine years later, described it plainly: it had “functioned as a public relations operation.”
The Frank Statement set the template for everything that followed. When the US Surgeon General’s report of 1964 concluded that cigarette smoking caused lung cancer — the most authoritative official statement on the subject to that point — Philip Morris issued its public response. “We don’t accept the idea that there are harmful agents in tobacco.” The company held that position for thirty-five more years — and the Big Tobacco cancer cover-up had officially begun.
The Cracks
The strategy required coordination. A single company maintaining a position was a corporate PR problem. Seven companies in six countries maintaining the same position simultaneously, in the face of mounting evidence, required something more organised.
The evidence had been building since before the Frank Statement was published. In 1950, British epidemiologists Richard Doll and Austin Bradford Hill published a landmark study in the British Medical Journal directly linking cigarette smoking to lung cancer. Their methodology was rigorous and their conclusions were clear. The tobacco industry’s response was to question the methodology. When further studies confirmed Doll and Hill’s findings, the industry questioned those too. This was not scientific scepticism. It was a protocol.
The Tobacco Industry Research Committee, the “independent” body announced alongside the Frank Statement in 1954, was designed to give the impression that the industry was taking the science seriously. It was chaired by a credentialed scientist, Clarence Cook Little, to establish credibility. Internally, the function was different. The TIRC funded research into cancer biology, genetics, immunology — areas carefully selected because they were unlikely to produce findings that linked smoking directly to disease. In 1989, a survey of TIRC-funded scientists asked grantees whether their research had anything to do with understanding the relationship between smoking and health. Only one in six answered yes.
In June 1977, the chairmen and chief executives of seven of the world’s major tobacco companies met in secret at Shockerwick House, a country house in England, at the invitation of Tony Garrett, Chairman of Imperial Tobacco. The attendees represented Philip Morris, R.J. Reynolds, British-American Tobacco, Rothmans, Reemtsma, Gallaher and Imperial. The meeting had a name: Operation Berkshire.
The objective, as recorded in the minutes marked “strictly confidential — limited circulation,” was to develop a unified defensive strategy on smoking and health — to avoid, as Garrett put it, companies being “picked off one by one, with a resultant domino effect.” The companies agreed to create a front organisation, the International Committee on Smoking Issues, later renamed INFOTAB, to coordinate their public positions across national boundaries. The minutes recorded Imperial Tobacco making concessions on lung cancer and pregnancy “by implication rather than direct admission.” The Philip Morris and British-American Tobacco position paper circulated beforehand stressed “the need for confidentiality and security,” noting that neither company “would wish the paper to fall into the wrong hands.”
The front cracked from the inside. In 1988, Merrell Williams was hired as a paralegal at a Louisville law firm handling Brown & Williamson’s litigation defence. Over four years, he made copies of thousands of pages of internal company documents — research files, strategy memos, legal communications — and removed them from the building. In 1994, those documents were passed to Representative Henry Waxman, who had been conducting congressional hearings into tobacco industry practices. Waxman read them into the congressional record under the protection of the Speech and Debate Clause, making them permanently public. Brown & Williamson responded by subpoenaing two sitting members of Congress — Waxman and Representative Ron Wyden — in an attempt to force them to hand over the material and identify its source. The federal court quashed both subpoenas.
That same year, thousands of additional pages of Brown & Williamson documents were donated anonymously to the University of California San Francisco. Brown & Williamson filed suit to suppress them. The California Supreme Court rejected the appeal. The documents were made public.
Meanwhile, inside the industry, the private assessment of their own position had been deteriorating for years. A British-American Tobacco internal document from 1980 recorded with unusual candour that the company’s public position on causation was “simply not believed by the overwhelming majority of independent observers, scientists and doctors,” and that maintaining it was becoming an existential liability. The companies kept maintaining it. By 1994, the documents Merrell Williams had carried out of that Louisville law firm were about to make that position untenable.
What the Documents Showed
The Yeaman memo was not a rogue observation by a single lawyer who had seen too much. It was consistent with a pattern that ran across every major tobacco company for decades.
In 1961, the Arthur D. Little Company provided a confidential report to Liggett & Myers Tobacco. The report described the biologically active materials present in cigarette tobacco in three categories: cancer causing, cancer promoting, and poisonous. In 1962, R.J. Reynolds scientist Dr Alan Rodgman wrote internally that the evidence implicating cigarette smoking as a health risk was “overwhelming,” and the evidence challenging that conclusion was “scant.” These were the companies’ own scientists, writing for internal audiences, with no reason to overstate.
Then came the documents the industry had never intended anyone to read.
“Moreover, nicotine is addictive. We are, then, in the business of selling nicotine, an addictive drug effective in the relief of stress mechanisms.”
Addison Yeaman, General Counsel, Brown & Williamson, 17 July 1963 (Bates No. 1802.05). On the same day this memo was written, Yeaman received a cable from BAT instructing him that sharing the company’s nicotine research with Surgeon General Luther Terry — who was then preparing the landmark 1964 report — was “undesirable.” Yeaman agreed. The research was withheld. The 1964 Surgeon General’s report classified nicotine as a “habituation” rather than an addiction. That classification held for twenty-four years.
Six years after Yeaman’s memo, the strategy for managing the public had been fully systematised. A Brown & Williamson internal document from 1969 stated its purpose with the directness that internal documents, unlike public ones, can afford.
“Doubt is our product, since it is the best means of competing with the body of fact that exists in the mind of the general public. It is also the means of establishing a controversy.”
Brown & Williamson internal document, 1969 (Bates No. 690010951/0959). This was not metaphor. It was a stated operational objective, written down, distributed within the company, and acted upon for the next three decades. The manufacture of public uncertainty as a deliberate corporate strategy was not an accusation levelled at the industry by its critics. It was a policy the industry had written for itself.
The concealment extended further than nicotine. Internal tobacco industry documents, analysed by researchers at UCLA from material released under the 1998 settlement, revealed that tobacco companies had known cigarettes contained polonium-210 — a radioactive substance — from at least 1959. The industry had conducted detailed internal research into the cancer risk this posed. It had identified a technique to remove the polonium-210 from tobacco leaves as early as 1959, and a second method in 1980. Neither was adopted. The reason given internally: the acid-wash process that removed the radioactive material would also ionise the nicotine, reducing its absorption rate and depriving smokers of the immediate rush that sustained addiction. They left the radioactive material in.
By 1980, the industry’s own internal documents recorded a frank assessment of its position. A British-American Tobacco document that year stated:
“The company’s position on causation is simply not believed by the overwhelming majority of independent observers, scientists and doctors… our position on causation, which we have maintained for some twenty years in order to defend our industry, is in danger of becoming the very factor which inhibits our long term viability.”
The document reviewed the options. It concluded that the industry should continue to maintain its position on causation.
They knew. They had always known. And they had decided, in writing, that knowing did not change anything.
The Executives Under Oath
On 14 April 1994, the seven chief executives of America’s largest tobacco companies filed into a congressional hearing room in Washington. Representative Henry Waxman had convened the House Subcommittee on Health and the Environment. For the first time in history, the heads of the tobacco industry had been subpoenaed to appear together and answer questions under oath. Waxman had made clear that if they did not appear, their chairs would sit empty on national television. They appeared.
Representative Ron Wyden of Oregon asked them, one by one, whether they believed nicotine was addictive. William Campbell of Philip Morris said he believed nicotine was not addictive. James Johnston of R.J. Reynolds said cigarettes and nicotine “clearly do not meet the classic definition of addiction.” Joseph Taddeo of US Tobacco said he did not believe nicotine or their products were addictive. Andrew Tisch of Lorillard said he believed nicotine was not addictive. Edward Horrigan of Liggett Group said he believed nicotine was not addictive. Thomas Sandefur of Brown & Williamson — the company whose files contained the Yeaman memo of 1963 — confirmed the same. Donald Johnston of American Tobacco said he too believed nicotine was not addictive.
The hearing was filmed. The image of seven men in suits seated in a row, right hands raised, became one of the most widely reproduced photographs in the history of American corporate accountability. Within weeks, internal documents contradicting their testimony were appearing in newspapers across the country.
Two weeks after the April hearing, two former Philip Morris scientists, Dr Victor DeNoble and Dr Paul Mele, testified before the same subcommittee. They had been conducting research in the early 1980s demonstrating that nicotine was highly addictive — research that showed rats would repeatedly press a lever to receive nicotine injections, building tolerance over time in patterns identical to those seen with heroin and cocaine. Philip Morris had shut down their laboratory in 1984 and prohibited them from publishing their findings. DeNoble and Mele told the subcommittee what their research had shown. Their testimony directly contradicted what the seven executives had said eleven days earlier. Brown & Williamson’s own 1963 memo had already done the same.
Meanwhile, Jeffrey Wigand was trying to decide whether to talk. Wigand had been Vice President of Research and Development at Brown & Williamson, hired in January 1989 to develop reduced-harm cigarettes. He was, by background, a health scientist — he had worked for Pfizer and Johnson & Johnson before joining the tobacco industry. What he found inside Brown & Williamson did not match the public position the company maintained. Executives were adding ammonia to tobacco to increase the rate at which nicotine was absorbed into the brain. They were developing a new high-nicotine product he believed posed acute risks. When he raised concerns about carcinogenic additives being used in the manufacturing process, he was told to drop it. He was fired on 24 March 1993.
He had signed a confidentiality agreement before he left. Brown & Williamson intended to hold him to it. The company hired Terry Lenzner’s Investigative Group International to compile a dossier on Wigand — 500 pages of personal and professional material, including claims about his character and personal life — and distributed it to media organisations across the country. The message was clear: if Wigand talked, they would destroy him. Anonymous death threats arrived at his home. He later described finding a bullet in his mailbox. The FBI opened an investigation into the threats. An ex-FBI agent working for Brown & Williamson’s investigators was subsequently identified as having used contacts at the agency’s local field office to conduct surveillance on Wigand’s behalf of the company.
Wigand agreed to be interviewed by Lowell Bergman, a producer at CBS’s 60 Minutes. The interview was recorded in 1995. What followed was not broadcast. CBS’s parent company was in the middle of a multi-billion dollar acquisition by Westinghouse. Lawyers warned that airing the interview could expose CBS to a tortious interference lawsuit from Brown & Williamson — a claim that the network had induced Wigand to breach his confidentiality agreement — and that such a lawsuit could put the entire acquisition at risk. The network’s senior management instructed that the interview be killed. The decision was made by corporate executives with strong financial incentives to avoid confrontation with the tobacco industry. Mike Wallace, 60 Minutes’ most senior correspondent, initially acquiesced. Lowell Bergman did not.
The story of the suppressed interview became a story in its own right. The Wall Street Journal and the New York Times both reported on what CBS had done and why. The suppression of a major news investigation by a network protecting its own financial interests was itself news. Public pressure mounted. Eventually, after 46 states had filed Medicaid lawsuits against the tobacco industry and the broader scandal had become impossible to contain, CBS aired the full interview on 4 February 1996. Wigand described the ammonia manipulation, the carcinogenic additives, and the internal knowledge at the most senior levels of what the products did to the people who used them. The broadcast was watched by tens of millions of people. Brown & Williamson’s lawsuit against Wigand was subsequently dropped as a condition of the 1997 settlement negotiations.
Forty-six states had filed Medicaid lawsuits seeking reimbursement for the healthcare costs generated by tobacco-related illness. In 1998, the Master Settlement Agreement was signed. The five major tobacco companies — Philip Morris, R.J. Reynolds, Lorillard, Brown & Williamson, and American Tobacco — agreed to pay $206 billion over twenty-five years and to release approximately 40 million pages of internal documents. Those documents are now held in the UCSF Truth Tobacco Industry Documents archive. The Yeaman memo is in there. So is the “Doubt is our product” document, the Operation Berkshire minutes, the suppressed DeNoble and Mele research files, and several thousand others like them.
A perjury investigation was opened by the Department of Justice. It went nowhere. The executives had not said nicotine was not addictive. They had said they believed nicotine was not addictive. The word had been chosen by lawyers before the hearing began. It could not be prosecuted. Not one of the seven served a day in prison.
How the Big Tobacco Cancer Cover-Up Became a Blueprint
The tobacco industry did not invent the suppression of inconvenient science. But it systematised it. The playbook developed between 1954 and 1998 — manufacture doubt, fund compliant research, create front organisations, attack individual scientists, stress the absence of certainty rather than the presence of evidence — became the template for how an industry facing existential regulatory threat responds.
The same firm, Hill & Knowlton, that designed the Frank Statement in 1954 later worked for other industries with similar problems. The same PR firms, in some cases the same individual consultants who had worked for tobacco companies, were subsequently retained elsewhere. The same tactics were adopted by the fossil fuel industry in the 1990s — targeting the scientific consensus, funding uncertainty, emphasising what was not yet proven rather than what was. The same playbook was used by pharmaceutical companies in the opioid crisis, with internal documents that would later prove executives knew precisely what they were denying.
The 40 million documents released under the 1998 settlement sit in a publicly searchable archive. The UCSF library that holds them has since added an Opioid Industry Documents Archive alongside the tobacco collection. The fossil fuel industry’s internal documents are beginning to surface in litigation. The playbook keeps acquiring new collections.
The internal documents released under the 1998 settlement revealed that the tobacco companies had known the truth since at least 1963. The fossil fuel industry hired some of the same consultants to run the same strategy on climate science. Those consultants are still working.
The Documents
- Yeaman, Addison. Internal memorandum, Brown & Williamson Tobacco Corporation. 17 July 1963. Bates No. 1802.05. UCSF Truth Tobacco Industry Documents
- Brown & Williamson Tobacco Corporation. “Smoking and Health Proposal.” 1969. Bates No. 690010951/0959. UCSF Truth Tobacco Industry Documents
- US House of Representatives, Subcommittee on Health and the Environment, Committee on Energy and Commerce. “Regulation of Tobacco Products (Part I), House Subcommittee on Health and the Environment, 14 April 1994.”
- Francey, Neil and Simon Chapman. “Operation Berkshire: The International Tobacco Companies’ Conspiracy.” British Medical Journal, Vol. 321, 2000.
- Karagueuzian, Hrayr S. et al. “Tobacco companies’ knowledge of radioactive polonium-210 in cigarettes.” Nicotine & Tobacco Research, 27 September 2011.
- United States v. Philip Morris USA Inc., et al. 449 F. Supp. 2d 1 (D.D.C. 2006). United States District Court, District of Columbia. Final Opinion, Judge Gladys Kessler, 17 August 2006.
Go Deeper
Robert N. Proctor, Golden Holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition (University of California Press, 2012)